News
It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...
The new pill is seen as a ‘major leap forward’ for hundreds of patients living with the rarest forms of cystic fibrosis ...
A new once daily triple drug treatment for cystic fibrosis is set to be “immediately funded” by NHS England following recommendation from the National Institute for Health and Care Excellence (NICE).1 ...
BETHESDA, Md. (July 16, 2025) – Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million ...
NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...
Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...
NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis ...
Taking a swing at cystic fibrosis, the “Spread Love” charity golf tournament is back in Montreal for its fourth year. Started by Montrealers Marco Gentile and Marco Colasurdo, the event supports the ...
Axtell spent 15 hours paddleboarding the gap between Bimini and Lake Worth Beach. Although stormy and hot weather made it ...
Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results